As investors are showing more interest for recent mega IPO listings, we have now introduced Kuaishou (1024 HK Equity) and JD Health (6618 HK Equity) as the latest additions to DLCs underlyings.

Investors can magnify the short term perspectives with daily 5x leverage for both sides of the trade.

Kuaishou

Last Close (59.200)
  • 62.200 +3 (+5.07%)
  • High 63.000
  • Low 60.600
  • Previous Close 59.200
  • Volume 39.4M
Last Update: 03/05/2024 18:00
Please refer to the Supplementary Listing Documents of the relevant DLC for the applicable risk factors, including those specific to weighted voting rights (WVR) stocks such as Kuaishou and JD Health both of which are controlled through WVR.

JD Health

Last Close (30.050)
  • 30.500 +0.45 (+1.50%)
  • High 31.250
  • Low 29.950
  • Previous Close 30.050
  • Volume 12.1M
Last Update: 03/05/2024 18:00
Please refer to the Supplementary Listing Documents of the relevant DLC for the applicable risk factors, including those specific to weighted voting rights (WVR) stocks such as Kuaishou and JD Health both of which are controlled through WVR.

Quick Facts about Underlying Asset

  • Quick Facts – Kuaishou

    “Globally, we are the largest live streaming platform by gross billings from virtual gifting and average live streaming MPUs (Monthly Paying Users), the second largest short video platform by average DAUs (Daily Active Users), and the second largest live streaming e-commerce platform by GMV (Gross Merchandise Value), all for the nine months ended September 30, 2020, according to iResearch.”

    Source: Kuaishou prospectus, published as of 26 January 2021

    Business focus: Entertainment, online marketing services, e-commerce, online games, online knowledge-sharing

    Market cap: USD 174.46 bn (as of 24 February 2021)
    HK IPO Size: USD 5.32 bn
    HK IPO Price: HKD 115.00
    HK IPO listing date: 5 February 2021
    Over subscription 1203x
    • Biggest technology IPO ever, as of 24 February 2021
    • The weighted voting right structure was adopted
    Source: Bloomberg, as of 24 February 2021
  • Quick Facts – JD Health

    “According to the Frost & Sullivan Report, we are the largest online healthcare platform by revenue in China in 2019, recording a total revenue of RMB10.8 billion. We are also the largest online retail pharmacy by revenue in China in 2019 with a market share of 29.8%, according to the Frost & Sullivan Report.”

    Source: JD Health prospectus, as of 26 November 2021

    Business focus: Retail pharmacy, online healthcare services

    Market cap: USD 59.20 bn (as of 24 February 2021)
    HK IPO Size: USD 3.48 bn
    HK IPO Price: HKD 70.58
    HK IPO listing date: 8 December 2020
    Over subscription 421x
    • Biggest IPO in Hong Kong in Year 2020
    • The weighted voting right structure was adopted
    Source: Bloomberg, as of 24 February 2021

Disclaimer

This advertisement has not been reviewed by the Monetary Authority of Singapore (“MAS”). This advertisement is distributed in Singapore by MAS licensed representatives of Société Générale, Singapore Branch. If you wish to discuss this advertisement, you should do so with your financial adviser, authorised broker or with MAS licensed representatives of Société Générale, Singapore Branch. This advertisement does not constitute or form part of any offer, or invitation, to subscribe for or to sell, or solicitation of any offer to subscribe for or to purchase, any certificates on indices/equities (the “Certificates” or “Daily Leverage Certificates”), warrants or other securities. Nothing herein should be considered as investment or financial advice or any form of recommendation to purchase or sell the Certificates/Daily Leverage Certificates, warrants or other securities mentioned. Information herein is intended as general information only and does not take into account the specific investment objectives, financial situation and the particular needs of any particular person. The price of Certificates/Daily Leverage Certificates, warrants or other securities and/or the price of the underlying asset may fall in value as rapidly as it may rise and holders may sustain a total loss of their investment. Investments in the Certificates/Daily Leverage Certificates, warrants or other securities carry risks. Any past performance of the Certificates/Daily Leverage Certificates, warrants or other securities, or past performance of an underlying asset, is not indicative of future performance. This document does not constitute a full disclosure of the risks involved. Members of the Société Générale group and/or its connected persons may take proprietary positions and may have long or short positions or other interests in the Certificates/Daily Leverage Certificates, warrants or other securities and may purchase and/or sell the Certificates/Daily Leverage Certificates, warrants/ or other securities at any time in the open market or otherwise, in each case whether as principal, agent or market maker.

The Certificates/Daily Leverage Certificates are for specified investment products (SIP) qualified investors only.

The terms and conditions of any Certificates/Daily Leverage Certificates, warrants or other securities must be read in conjunction with the base listing documents for those Certificates/Daily Leverage Certificates, warrants or other securities and the relevant supplemental listing document. Investors should therefore ensure that they understand the nature of the Certificates/Daily Leverage Certificates, warrants or other securities and carefully study the risk factors set out in the base listing document and the relevant supplemental listing documents and, where necessary, seek professional advice before investors invest in the Certificates/Daily Leverage Certificates, warrants or other securities. Copies of the base listing document, which contains financial and other information relating to the Issuer and any addenda thereto and the relevant supplemental listing documents, which contain details of the Certificates/Daily Leverage Certificates, warrants or other securities, can be obtained from the Allen & Gledhill LLP at One Marina Boulevard #28-00, Singapore 018989.  Investors should read these documents in their entirety before agreeing to invest in the Certificates/Daily Leverage Certificates, warrants or other securities. This is a structured product which involves derivatives and investors should not invest without fully understanding and being willing to assume all risks associated with the Certificates/Daily Leverage Certificates, warrants or other securities. Investors should ensure they understand the risks, nature, terms and conditions of the Certificates/Daily Leverage Certificates, warrants or other securities and consult their own legal, financial, tax and professional advisers regarding the suitability and risks before committing to any investment.

Investors risk the loss of part or all of their investment. Investment in the Certificates/Daily Leverage Certificates, warrants or other securities involves significant levels of risks and the Certificates/Daily Leverage Certificates, warrants or other securities should only be purchased by investors who are knowledgeable in investment matters or who have obtained appropriate investment advice.

Société Générale and its affiliates (the “SG Group”) act in different capacities in relation to the issue of the Certificates/Daily Leverage Certificates, warrants or other securities. SG Issuer is the issuer of the Certificates/Daily Leverage Certificates, warrants or other securities (the “Issuer”), Société Générale acts as designated market maker for the Certificates/Daily Leverage Certificates, warrants or other securities. Société Générale, Singapore Branch is also authorized to distribute and market the Certificates/Daily Leverage Certificates, warrants or other securities to its customers. For the avoidance of doubt and as an independent stipulation, investors agree that by purchasing the Certificates/Daily Leverage Certificates, warrants or other securities, the SG Group may provide different services and/or perform different roles in relation to the issuance, offer and/or dealing in the Certificates/Daily Leverage Certificates, warrants or other securities. The investor acknowledges and agrees that the provision of such services or the undertaking of such roles may not always be consistent with the interests of the issuer and/or the investors. The investor agrees that subject to mandatory applicable law which the SG Group cannot derogate from, no implied duties or obligations shall be imposed on SG Group to the investor under the Certificates/Daily Leverage Certificates, warrants or other securities, and in connection with or as a result of the investor’s subscription or purchase of the Certificates/Daily Leverage Certificates, warrants or other securities. The Issuer or Société Générale may have a position or a material interest in any underlying asset.

The Issuer, Société Générale or any of their affiliates may engage in transactions involving the underlying asset for their own account for business reasons or in connection with hedging of the obligation under this Certificates/Daily Leverage Certificates, warrant or other securities. Conflicts of interest may arise as a result of such transactions within the SG Group and with the interest of investors. The Issuer, Société Générale and their affiliates are not required to consider any investors’ interests in connection with entering into any of the above mentioned transactions.

The Issuer, Société Générale and their affiliates may receive benefits and/or profits as a result of its multiple roles as designated market maker and/or distributor (whether in the nature of a fiduciary, similar or additional duty or relationship or otherwise) and fully consents to the retention of such benefits and/or profits for their own account. Each investor acknowledges and agrees that none of the Issuer, Société Générale and their affiliates is obliged to notify, and is liable to account to, an investor or any other person for (and each investor or such other person shall not be entitled to ask for disclosure of the fact or the amount of, any fees resulting from any of the aforementioned roles, other than is already disclosed in the offering documents for the Certificates/Daily Leverage Certificates, warrants or other securities. Each investor agrees that the investor will have no claim against the Issuer, Société Générale and their affiliates for, and the investor consents to the receipt, acceptance and retention by the Issuer, Société Générale and their affiliates of, such fees arising from any such multiple roles.

Société Générale does not make any warranty, express or implied, as to the accuracy or completeness of the information contained herein. No responsibility or liability is accepted by Société Générale for any inaccuracies, omissions, mistakes or errors of Société Générale in the computation of the cash settlement amount or for any economic or other loss which may be directly or indirectly sustained by any broker or holder of the Certificates/Daily Leverage Certificates, warrants or other securities or any other person dealing with the Certificates/Daily Leverage Certificates, warrants or other securities as a result thereof and no claims, actions or legal proceedings may be brought against Société Générale in connection with the Certificates/Daily Leverage Certificates, warrants or other securities in any manner whatsoever by any broker, holder or other person dealing with the Certificates/Daily Leverage Certificates, warrants or other securities. Any broker, holder or other person dealing with the Certificates/Daily Leverage Certificates, warrants or other securities does so therefore in full knowledge of this disclaimer and can place no reliance whatsoever on Société Générale. For the avoidance of doubt, this disclaimer does not create any contractual or quasi-contractual relationship between any broker, holder or other person and Société Générale and must not be construed to have created such relationship.

The Certificates/Daily Leverage Certificates, warrants or other securities are not deposits placed with Société Générale.